nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—TUBB—dilated cardiomyopathy	0.572	1	CbGaD
Paclitaxel—ABCC2—Spironolactone—dilated cardiomyopathy	0.0736	0.35	CbGbCtD
Paclitaxel—ABCC2—Furosemide—dilated cardiomyopathy	0.0503	0.239	CbGbCtD
Paclitaxel—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0355	0.168	CbGbCtD
Paclitaxel—ABCB1—Lisinopril—dilated cardiomyopathy	0.0273	0.129	CbGbCtD
Paclitaxel—ABCB1—Spironolactone—dilated cardiomyopathy	0.024	0.114	CbGbCtD
Paclitaxel—CYP2C9—cardial valve—dilated cardiomyopathy	0.0057	0.161	CbGeAlD
Paclitaxel—Cabazitaxel—TUBB—dilated cardiomyopathy	0.00294	0.488	CrCbGaD
Paclitaxel—Docetaxel—TUBB—dilated cardiomyopathy	0.00237	0.394	CrCbGaD
Paclitaxel—MAP4—myocardium—dilated cardiomyopathy	0.00176	0.0498	CbGeAlD
Paclitaxel—MAPT—heart—dilated cardiomyopathy	0.00157	0.0442	CbGeAlD
Paclitaxel—MAP2—cardiac ventricle—dilated cardiomyopathy	0.00148	0.0417	CbGeAlD
Paclitaxel—MAP2—myocardium—dilated cardiomyopathy	0.00139	0.0392	CbGeAlD
Paclitaxel—MAP4—heart—dilated cardiomyopathy	0.00123	0.0348	CbGeAlD
Paclitaxel—BCL2—heart—dilated cardiomyopathy	0.00112	0.0316	CbGeAlD
Paclitaxel—TUBB—cardiac ventricle—dilated cardiomyopathy	0.00104	0.0295	CbGeAlD
Paclitaxel—TUBB2A—cardiac ventricle—dilated cardiomyopathy	0.00104	0.0293	CbGeAlD
Paclitaxel—TUBB6—cardiac ventricle—dilated cardiomyopathy	0.00102	0.0289	CbGeAlD
Paclitaxel—TUBB—myocardium—dilated cardiomyopathy	0.000981	0.0277	CbGeAlD
Paclitaxel—TUBB2A—myocardium—dilated cardiomyopathy	0.000976	0.0276	CbGeAlD
Paclitaxel—MAP2—heart—dilated cardiomyopathy	0.000969	0.0274	CbGeAlD
Paclitaxel—TUBB6—myocardium—dilated cardiomyopathy	0.000963	0.0272	CbGeAlD
Paclitaxel—ABCC10—cardiac ventricle—dilated cardiomyopathy	0.000896	0.0253	CbGeAlD
Paclitaxel—TUBB4B—cardiac ventricle—dilated cardiomyopathy	0.00089	0.0251	CbGeAlD
Paclitaxel—TUBB4B—myocardium—dilated cardiomyopathy	0.000837	0.0236	CbGeAlD
Paclitaxel—MAP2—cardiac atrium—dilated cardiomyopathy	0.000829	0.0234	CbGeAlD
Paclitaxel—TUBB4A—heart—dilated cardiomyopathy	0.000749	0.0212	CbGeAlD
Paclitaxel—TUBB2B—heart—dilated cardiomyopathy	0.000724	0.0205	CbGeAlD
Paclitaxel—Docetaxel—EGFR—dilated cardiomyopathy	0.000704	0.117	CrCbGaD
Paclitaxel—TUBB—heart—dilated cardiomyopathy	0.000685	0.0194	CbGeAlD
Paclitaxel—TUBB2A—heart—dilated cardiomyopathy	0.000681	0.0193	CbGeAlD
Paclitaxel—TUBB6—heart—dilated cardiomyopathy	0.000672	0.019	CbGeAlD
Paclitaxel—TUBB2B—cardiac atrium—dilated cardiomyopathy	0.000619	0.0175	CbGeAlD
Paclitaxel—ABCC1—myocardium—dilated cardiomyopathy	0.000596	0.0168	CbGeAlD
Paclitaxel—ABCC10—heart—dilated cardiomyopathy	0.000588	0.0166	CbGeAlD
Paclitaxel—TUBB—cardiac atrium—dilated cardiomyopathy	0.000586	0.0166	CbGeAlD
Paclitaxel—TUBB4B—heart—dilated cardiomyopathy	0.000584	0.0165	CbGeAlD
Paclitaxel—TUBB2A—cardiac atrium—dilated cardiomyopathy	0.000583	0.0165	CbGeAlD
Paclitaxel—TUBB6—cardiac atrium—dilated cardiomyopathy	0.000575	0.0162	CbGeAlD
Paclitaxel—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000568	0.00636	CcSEcCtD
Paclitaxel—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.000568	0.00636	CcSEcCtD
Paclitaxel—Throat sore—Lisinopril—dilated cardiomyopathy	0.000563	0.0063	CcSEcCtD
Paclitaxel—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.000558	0.00624	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000552	0.00617	CcSEcCtD
Paclitaxel—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.000549	0.00614	CcSEcCtD
Paclitaxel—Renal failure—Spironolactone—dilated cardiomyopathy	0.000547	0.00612	CcSEcCtD
Paclitaxel—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.000539	0.00603	CcSEcCtD
Paclitaxel—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00053	0.00593	CcSEcCtD
Paclitaxel—ABCC10—cardiac atrium—dilated cardiomyopathy	0.000503	0.0142	CbGeAlD
Paclitaxel—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.000501	0.00561	CcSEcCtD
Paclitaxel—TUBB4B—cardiac atrium—dilated cardiomyopathy	0.0005	0.0141	CbGeAlD
Paclitaxel—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000497	0.00556	CcSEcCtD
Paclitaxel—Urine output increased—Furosemide—dilated cardiomyopathy	0.000489	0.00547	CcSEcCtD
Paclitaxel—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000484	0.00542	CcSEcCtD
Paclitaxel—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000472	0.00528	CcSEcCtD
Paclitaxel—Mental disability—Furosemide—dilated cardiomyopathy	0.00047	0.00525	CcSEcCtD
Paclitaxel—Breast pain—Lisinopril—dilated cardiomyopathy	0.000465	0.00521	CcSEcCtD
Paclitaxel—CYP1B1—heart—dilated cardiomyopathy	0.000463	0.0131	CbGeAlD
Paclitaxel—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.000459	0.00513	CcSEcCtD
Paclitaxel—Accidental injury—Lisinopril—dilated cardiomyopathy	0.000459	0.00513	CcSEcCtD
Paclitaxel—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000454	0.00508	CcSEcCtD
Paclitaxel—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000449	0.00503	CcSEcCtD
Paclitaxel—Viral infection—Lisinopril—dilated cardiomyopathy	0.000449	0.00503	CcSEcCtD
Paclitaxel—Polyuria—Furosemide—dilated cardiomyopathy	0.000447	0.005	CcSEcCtD
Paclitaxel—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000446	0.00499	CcSEcCtD
Paclitaxel—Swelling—Furosemide—dilated cardiomyopathy	0.000445	0.00498	CcSEcCtD
Paclitaxel—Alopecia—Spironolactone—dilated cardiomyopathy	0.000441	0.00494	CcSEcCtD
Paclitaxel—Deafness—Furosemide—dilated cardiomyopathy	0.000439	0.00491	CcSEcCtD
Paclitaxel—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000438	0.0049	CcSEcCtD
Paclitaxel—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000418	0.00468	CcSEcCtD
Paclitaxel—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000416	0.00466	CcSEcCtD
Paclitaxel—ABCC1—heart—dilated cardiomyopathy	0.000416	0.0118	CbGeAlD
Paclitaxel—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000411	0.0046	CcSEcCtD
Paclitaxel—Neck pain—Lisinopril—dilated cardiomyopathy	0.000411	0.0046	CcSEcCtD
Paclitaxel—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000406	0.00454	CcSEcCtD
Paclitaxel—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000406	0.00454	CcSEcCtD
Paclitaxel—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000403	0.00451	CcSEcCtD
Paclitaxel—Lethargy—Furosemide—dilated cardiomyopathy	0.000401	0.00448	CcSEcCtD
Paclitaxel—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000394	0.00441	CcSEcCtD
Paclitaxel—Wheezing—Lisinopril—dilated cardiomyopathy	0.000394	0.00441	CcSEcCtD
Paclitaxel—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000394	0.00441	CcSEcCtD
Paclitaxel—Malaise—Spironolactone—dilated cardiomyopathy	0.000392	0.00439	CcSEcCtD
Paclitaxel—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000389	0.00435	CcSEcCtD
Paclitaxel—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000385	0.00431	CcSEcCtD
Paclitaxel—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000381	0.00426	CcSEcCtD
Paclitaxel—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000368	0.00412	CcSEcCtD
Paclitaxel—Discomfort—Spironolactone—dilated cardiomyopathy	0.000366	0.00409	CcSEcCtD
Paclitaxel—Dehydration—Furosemide—dilated cardiomyopathy	0.000365	0.00409	CcSEcCtD
Paclitaxel—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000363	0.00406	CcSEcCtD
Paclitaxel—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000359	0.00401	CcSEcCtD
Paclitaxel—Confusional state—Spironolactone—dilated cardiomyopathy	0.000358	0.004	CcSEcCtD
Paclitaxel—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000357	0.004	CcSEcCtD
Paclitaxel—ABCC1—cardiac atrium—dilated cardiomyopathy	0.000356	0.0101	CbGeAlD
Paclitaxel—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000356	0.00398	CcSEcCtD
Paclitaxel—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000355	0.00397	CcSEcCtD
Paclitaxel—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000354	0.00396	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000354	0.00396	CcSEcCtD
Paclitaxel—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000347	0.00389	CcSEcCtD
Paclitaxel—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000346	0.00388	CcSEcCtD
Paclitaxel—ABCG2—heart—dilated cardiomyopathy	0.000344	0.00973	CbGeAlD
Paclitaxel—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000342	0.00382	CcSEcCtD
Paclitaxel—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000333	0.00372	CcSEcCtD
Paclitaxel—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000323	0.00362	CcSEcCtD
Paclitaxel—Injury—Lisinopril—dilated cardiomyopathy	0.000321	0.00359	CcSEcCtD
Paclitaxel—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000319	0.00357	CcSEcCtD
Paclitaxel—Somnolence—Spironolactone—dilated cardiomyopathy	0.000315	0.00353	CcSEcCtD
Paclitaxel—CYP2C9—heart—dilated cardiomyopathy	0.000315	0.00889	CbGeAlD
Paclitaxel—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000314	0.00351	CcSEcCtD
Paclitaxel—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000311	0.00348	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00031	0.00347	CcSEcCtD
Paclitaxel—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00031	0.00346	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000306	0.00343	CcSEcCtD
Paclitaxel—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000306	0.00343	CcSEcCtD
Paclitaxel—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000302	0.00338	CcSEcCtD
Paclitaxel—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000301	0.00336	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0003	0.00336	CcSEcCtD
Paclitaxel—Renal failure—Furosemide—dilated cardiomyopathy	0.000298	0.00333	CcSEcCtD
Paclitaxel—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000296	0.00331	CcSEcCtD
Paclitaxel—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000295	0.0033	CcSEcCtD
Paclitaxel—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000292	0.00327	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000286	0.0032	CcSEcCtD
Paclitaxel—Urticaria—Spironolactone—dilated cardiomyopathy	0.000282	0.00315	CcSEcCtD
Paclitaxel—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00028	0.00314	CcSEcCtD
Paclitaxel—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00028	0.00313	CcSEcCtD
Paclitaxel—Ataxia—Lisinopril—dilated cardiomyopathy	0.000277	0.0031	CcSEcCtD
Paclitaxel—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000276	0.00309	CcSEcCtD
Paclitaxel—Dehydration—Lisinopril—dilated cardiomyopathy	0.000274	0.00307	CcSEcCtD
Paclitaxel—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000269	0.00301	CcSEcCtD
Paclitaxel—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000268	0.003	CcSEcCtD
Paclitaxel—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000266	0.00298	CcSEcCtD
Paclitaxel—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000266	0.00298	CcSEcCtD
Paclitaxel—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000265	0.00297	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000265	0.00297	CcSEcCtD
Paclitaxel—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000264	0.00295	CcSEcCtD
Paclitaxel—Visual impairment—Furosemide—dilated cardiomyopathy	0.000262	0.00293	CcSEcCtD
Paclitaxel—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000261	0.00292	CcSEcCtD
Paclitaxel—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000257	0.00287	CcSEcCtD
Paclitaxel—Influenza—Lisinopril—dilated cardiomyopathy	0.000255	0.00285	CcSEcCtD
Paclitaxel—Eye disorder—Furosemide—dilated cardiomyopathy	0.000254	0.00284	CcSEcCtD
Paclitaxel—Tinnitus—Furosemide—dilated cardiomyopathy	0.000253	0.00283	CcSEcCtD
Paclitaxel—Pruritus—Spironolactone—dilated cardiomyopathy	0.000251	0.00281	CcSEcCtD
Paclitaxel—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00025	0.00279	CcSEcCtD
Paclitaxel—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000248	0.00278	CcSEcCtD
Paclitaxel—Angiopathy—Furosemide—dilated cardiomyopathy	0.000247	0.00276	CcSEcCtD
Paclitaxel—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000245	0.00275	CcSEcCtD
Paclitaxel—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000245	0.00274	CcSEcCtD
Paclitaxel—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000243	0.00272	CcSEcCtD
Paclitaxel—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000243	0.00272	CcSEcCtD
Paclitaxel—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000242	0.00271	CcSEcCtD
Paclitaxel—Dysuria—Lisinopril—dilated cardiomyopathy	0.000238	0.00266	CcSEcCtD
Paclitaxel—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000238	0.00266	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000237	0.00265	CcSEcCtD
Paclitaxel—Erythema—Furosemide—dilated cardiomyopathy	0.000237	0.00265	CcSEcCtD
Paclitaxel—Malnutrition—Furosemide—dilated cardiomyopathy	0.000237	0.00265	CcSEcCtD
Paclitaxel—Dizziness—Spironolactone—dilated cardiomyopathy	0.000235	0.00262	CcSEcCtD
Paclitaxel—Flatulence—Furosemide—dilated cardiomyopathy	0.000233	0.00261	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000232	0.0026	CcSEcCtD
Paclitaxel—Weight increased—Lisinopril—dilated cardiomyopathy	0.000232	0.00259	CcSEcCtD
Paclitaxel—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000232	0.00259	CcSEcCtD
Paclitaxel—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00023	0.00258	CcSEcCtD
Paclitaxel—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00023	0.00257	CcSEcCtD
Paclitaxel—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000228	0.00256	CcSEcCtD
Paclitaxel—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000227	0.00254	CcSEcCtD
Paclitaxel—Depression—Lisinopril—dilated cardiomyopathy	0.000226	0.00253	CcSEcCtD
Paclitaxel—Vomiting—Spironolactone—dilated cardiomyopathy	0.000226	0.00252	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000225	0.00252	CcSEcCtD
Paclitaxel—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000224	0.0025	CcSEcCtD
Paclitaxel—Rash—Spironolactone—dilated cardiomyopathy	0.000224	0.0025	CcSEcCtD
Paclitaxel—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000224	0.0025	CcSEcCtD
Paclitaxel—Renal failure—Lisinopril—dilated cardiomyopathy	0.000223	0.0025	CcSEcCtD
Paclitaxel—Vision blurred—Furosemide—dilated cardiomyopathy	0.000223	0.00249	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000223	0.00249	CcSEcCtD
Paclitaxel—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000223	0.00249	CcSEcCtD
Paclitaxel—Headache—Spironolactone—dilated cardiomyopathy	0.000222	0.00249	CcSEcCtD
Paclitaxel—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000221	0.00247	CcSEcCtD
Paclitaxel—Anaemia—Furosemide—dilated cardiomyopathy	0.000219	0.00245	CcSEcCtD
Paclitaxel—Agitation—Furosemide—dilated cardiomyopathy	0.000217	0.00243	CcSEcCtD
Paclitaxel—Haematuria—Lisinopril—dilated cardiomyopathy	0.000217	0.00242	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000215	0.0024	CcSEcCtD
Paclitaxel—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000214	0.0024	CcSEcCtD
Paclitaxel—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000213	0.00238	CcSEcCtD
Paclitaxel—Vertigo—Furosemide—dilated cardiomyopathy	0.000213	0.00238	CcSEcCtD
Paclitaxel—Leukopenia—Furosemide—dilated cardiomyopathy	0.000212	0.00237	CcSEcCtD
Paclitaxel—Nausea—Spironolactone—dilated cardiomyopathy	0.000211	0.00236	CcSEcCtD
Paclitaxel—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000208	0.00232	CcSEcCtD
Paclitaxel—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000204	0.00229	CcSEcCtD
Paclitaxel—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000202	0.00226	CcSEcCtD
Paclitaxel—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000201	0.00225	CcSEcCtD
Paclitaxel—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000201	0.00225	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0002	0.00224	CcSEcCtD
Paclitaxel—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.0002	0.00224	CcSEcCtD
Paclitaxel—Dry mouth—Furosemide—dilated cardiomyopathy	0.000197	0.0022	CcSEcCtD
Paclitaxel—Confusional state—Furosemide—dilated cardiomyopathy	0.000195	0.00218	CcSEcCtD
Paclitaxel—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000193	0.00216	CcSEcCtD
Paclitaxel—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000193	0.00216	CcSEcCtD
Paclitaxel—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00019	0.00213	CcSEcCtD
Paclitaxel—Shock—Furosemide—dilated cardiomyopathy	0.00019	0.00212	CcSEcCtD
Paclitaxel—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000189	0.00212	CcSEcCtD
Paclitaxel—Flushing—Lisinopril—dilated cardiomyopathy	0.000189	0.00212	CcSEcCtD
Paclitaxel—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000189	0.00211	CcSEcCtD
Paclitaxel—Skin disorder—Furosemide—dilated cardiomyopathy	0.000188	0.0021	CcSEcCtD
Paclitaxel—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000187	0.00209	CcSEcCtD
Paclitaxel—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000185	0.00207	CcSEcCtD
Paclitaxel—Anorexia—Furosemide—dilated cardiomyopathy	0.000184	0.00206	CcSEcCtD
Paclitaxel—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000184	0.00206	CcSEcCtD
Paclitaxel—Chills—Lisinopril—dilated cardiomyopathy	0.000183	0.00205	CcSEcCtD
Paclitaxel—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000182	0.00204	CcSEcCtD
Paclitaxel—Hypotension—Furosemide—dilated cardiomyopathy	0.00018	0.00202	CcSEcCtD
Paclitaxel—Alopecia—Lisinopril—dilated cardiomyopathy	0.00018	0.00202	CcSEcCtD
Paclitaxel—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000179	0.002	CcSEcCtD
Paclitaxel—Erythema—Lisinopril—dilated cardiomyopathy	0.000177	0.00199	CcSEcCtD
Paclitaxel—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000177	0.00199	CcSEcCtD
Paclitaxel—Flatulence—Lisinopril—dilated cardiomyopathy	0.000175	0.00196	CcSEcCtD
Paclitaxel—Tension—Lisinopril—dilated cardiomyopathy	0.000174	0.00195	CcSEcCtD
Paclitaxel—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000174	0.00194	CcSEcCtD
Paclitaxel—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000173	0.00194	CcSEcCtD
Paclitaxel—Nervousness—Lisinopril—dilated cardiomyopathy	0.000172	0.00193	CcSEcCtD
Paclitaxel—Back pain—Lisinopril—dilated cardiomyopathy	0.000172	0.00192	CcSEcCtD
Paclitaxel—Somnolence—Furosemide—dilated cardiomyopathy	0.000172	0.00192	CcSEcCtD
Paclitaxel—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000171	0.00191	CcSEcCtD
Paclitaxel—ABCB1—heart—dilated cardiomyopathy	0.00017	0.0048	CbGeAlD
Paclitaxel—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000168	0.00188	CcSEcCtD
Paclitaxel—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000167	0.00187	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000167	0.00186	CcSEcCtD
Paclitaxel—Fatigue—Furosemide—dilated cardiomyopathy	0.000166	0.00186	CcSEcCtD
Paclitaxel—Tremor—Lisinopril—dilated cardiomyopathy	0.000166	0.00186	CcSEcCtD
Paclitaxel—Pain—Furosemide—dilated cardiomyopathy	0.000165	0.00185	CcSEcCtD
Paclitaxel—Constipation—Furosemide—dilated cardiomyopathy	0.000165	0.00185	CcSEcCtD
Paclitaxel—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000165	0.00184	CcSEcCtD
Paclitaxel—Anaemia—Lisinopril—dilated cardiomyopathy	0.000164	0.00183	CcSEcCtD
Paclitaxel—Angioedema—Lisinopril—dilated cardiomyopathy	0.000162	0.00181	CcSEcCtD
Paclitaxel—Malaise—Lisinopril—dilated cardiomyopathy	0.00016	0.00179	CcSEcCtD
Paclitaxel—Vertigo—Lisinopril—dilated cardiomyopathy	0.000159	0.00178	CcSEcCtD
Paclitaxel—Syncope—Lisinopril—dilated cardiomyopathy	0.000159	0.00178	CcSEcCtD
Paclitaxel—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000159	0.00178	CcSEcCtD
Paclitaxel—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000159	0.00178	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000158	0.00177	CcSEcCtD
Paclitaxel—Palpitations—Lisinopril—dilated cardiomyopathy	0.000157	0.00175	CcSEcCtD
Paclitaxel—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000156	0.00174	CcSEcCtD
Paclitaxel—Cough—Lisinopril—dilated cardiomyopathy	0.000155	0.00173	CcSEcCtD
Paclitaxel—Urticaria—Furosemide—dilated cardiomyopathy	0.000153	0.00172	CcSEcCtD
Paclitaxel—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000153	0.00171	CcSEcCtD
Paclitaxel—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000153	0.00171	CcSEcCtD
Paclitaxel—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000151	0.00169	CcSEcCtD
Paclitaxel—Chest pain—Lisinopril—dilated cardiomyopathy	0.000151	0.00169	CcSEcCtD
Paclitaxel—Myalgia—Lisinopril—dilated cardiomyopathy	0.000151	0.00169	CcSEcCtD
Paclitaxel—Anxiety—Lisinopril—dilated cardiomyopathy	0.000151	0.00168	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00015	0.00168	CcSEcCtD
Paclitaxel—Discomfort—Lisinopril—dilated cardiomyopathy	0.000149	0.00167	CcSEcCtD
Paclitaxel—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000148	0.00165	CcSEcCtD
Paclitaxel—Confusional state—Lisinopril—dilated cardiomyopathy	0.000146	0.00163	CcSEcCtD
Paclitaxel—Oedema—Lisinopril—dilated cardiomyopathy	0.000145	0.00162	CcSEcCtD
Paclitaxel—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000145	0.00162	CcSEcCtD
Paclitaxel—Infection—Lisinopril—dilated cardiomyopathy	0.000144	0.00161	CcSEcCtD
Paclitaxel—Shock—Lisinopril—dilated cardiomyopathy	0.000143	0.00159	CcSEcCtD
Paclitaxel—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000142	0.00159	CcSEcCtD
Paclitaxel—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000142	0.00159	CcSEcCtD
Paclitaxel—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000141	0.00158	CcSEcCtD
Paclitaxel—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000141	0.00157	CcSEcCtD
Paclitaxel—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00014	0.00157	CcSEcCtD
Paclitaxel—Asthenia—Furosemide—dilated cardiomyopathy	0.000139	0.00155	CcSEcCtD
Paclitaxel—Anorexia—Lisinopril—dilated cardiomyopathy	0.000138	0.00154	CcSEcCtD
Paclitaxel—Pruritus—Furosemide—dilated cardiomyopathy	0.000137	0.00153	CcSEcCtD
Paclitaxel—Hypotension—Lisinopril—dilated cardiomyopathy	0.000135	0.00151	CcSEcCtD
Paclitaxel—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000132	0.00148	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000132	0.00148	CcSEcCtD
Paclitaxel—Insomnia—Lisinopril—dilated cardiomyopathy	0.000131	0.00147	CcSEcCtD
Paclitaxel—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00013	0.00145	CcSEcCtD
Paclitaxel—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000129	0.00144	CcSEcCtD
Paclitaxel—Somnolence—Lisinopril—dilated cardiomyopathy	0.000129	0.00144	CcSEcCtD
Paclitaxel—Dizziness—Furosemide—dilated cardiomyopathy	0.000128	0.00143	CcSEcCtD
Paclitaxel—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000127	0.00143	CcSEcCtD
Paclitaxel—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000126	0.00141	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000125	0.0014	CcSEcCtD
Paclitaxel—Fatigue—Lisinopril—dilated cardiomyopathy	0.000125	0.0014	CcSEcCtD
Paclitaxel—Constipation—Lisinopril—dilated cardiomyopathy	0.000124	0.00139	CcSEcCtD
Paclitaxel—Pain—Lisinopril—dilated cardiomyopathy	0.000124	0.00139	CcSEcCtD
Paclitaxel—Vomiting—Furosemide—dilated cardiomyopathy	0.000123	0.00137	CcSEcCtD
Paclitaxel—Rash—Furosemide—dilated cardiomyopathy	0.000122	0.00136	CcSEcCtD
Paclitaxel—Dermatitis—Furosemide—dilated cardiomyopathy	0.000122	0.00136	CcSEcCtD
Paclitaxel—Headache—Furosemide—dilated cardiomyopathy	0.000121	0.00135	CcSEcCtD
Paclitaxel—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000119	0.00134	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000118	0.00132	CcSEcCtD
Paclitaxel—Urticaria—Lisinopril—dilated cardiomyopathy	0.000115	0.00129	CcSEcCtD
Paclitaxel—Nausea—Furosemide—dilated cardiomyopathy	0.000115	0.00128	CcSEcCtD
Paclitaxel—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000115	0.00128	CcSEcCtD
Paclitaxel—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000115	0.00128	CcSEcCtD
Paclitaxel—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000107	0.00119	CcSEcCtD
Paclitaxel—Asthenia—Lisinopril—dilated cardiomyopathy	0.000104	0.00116	CcSEcCtD
Paclitaxel—Pruritus—Lisinopril—dilated cardiomyopathy	0.000102	0.00115	CcSEcCtD
Paclitaxel—Diarrhoea—Lisinopril—dilated cardiomyopathy	9.91e-05	0.00111	CcSEcCtD
Paclitaxel—Dizziness—Lisinopril—dilated cardiomyopathy	9.58e-05	0.00107	CcSEcCtD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.42e-05	0.00109	CbGpPWpGaD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—dilated cardiomyopathy	9.29e-05	0.00107	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.22e-05	0.00106	CbGpPWpGaD
Paclitaxel—Vomiting—Lisinopril—dilated cardiomyopathy	9.21e-05	0.00103	CcSEcCtD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.15e-05	0.00106	CbGpPWpGaD
Paclitaxel—Rash—Lisinopril—dilated cardiomyopathy	9.13e-05	0.00102	CcSEcCtD
Paclitaxel—Dermatitis—Lisinopril—dilated cardiomyopathy	9.12e-05	0.00102	CcSEcCtD
Paclitaxel—TUBB4B—Cell Cycle—ALMS1—dilated cardiomyopathy	9.12e-05	0.00105	CbGpPWpGaD
Paclitaxel—MAPT—Alzheimers Disease—TNF—dilated cardiomyopathy	9.11e-05	0.00105	CbGpPWpGaD
Paclitaxel—Headache—Lisinopril—dilated cardiomyopathy	9.07e-05	0.00102	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—GPX1—dilated cardiomyopathy	8.92e-05	0.00103	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.9e-05	0.00103	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.9e-05	0.00103	CbGpPWpGaD
Paclitaxel—MAPT—BDNF signaling pathway—RAF1—dilated cardiomyopathy	8.63e-05	0.000997	CbGpPWpGaD
Paclitaxel—Nausea—Lisinopril—dilated cardiomyopathy	8.6e-05	0.000962	CcSEcCtD
Paclitaxel—TUBB—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	8.52e-05	0.000983	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.37e-05	0.000966	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—FAS—dilated cardiomyopathy	8.35e-05	0.000964	CbGpPWpGaD
Paclitaxel—BCL2—Ceramide signaling pathway—TNF—dilated cardiomyopathy	8.35e-05	0.000964	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.27e-05	0.000956	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.14e-05	0.00094	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.14e-05	0.00094	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	8.02e-05	0.000927	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—FASLG—dilated cardiomyopathy	7.98e-05	0.000922	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—ITGB1—dilated cardiomyopathy	7.98e-05	0.000921	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—NR3C2—dilated cardiomyopathy	7.94e-05	0.000917	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.92e-05	0.000915	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.89e-05	0.000911	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	7.71e-05	0.00089	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—FAS—dilated cardiomyopathy	7.7e-05	0.000889	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.63e-05	0.000881	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	7.63e-05	0.000881	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TMPO—dilated cardiomyopathy	7.61e-05	0.000879	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	7.6e-05	0.000877	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.57e-05	0.000874	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.56e-05	0.000873	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.45e-05	0.00086	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.42e-05	0.000857	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.35e-05	0.000849	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.35e-05	0.000849	CbGpPWpGaD
Paclitaxel—BCL2—Caspase Cascade in Apoptosis—TNF—dilated cardiomyopathy	7.28e-05	0.00084	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.17e-05	0.000829	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	7.06e-05	0.000815	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	6.99e-05	0.000808	CbGpPWpGaD
Paclitaxel—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	6.96e-05	0.000804	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.89e-05	0.000795	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.84e-05	0.00079	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—RAF1—dilated cardiomyopathy	6.83e-05	0.000789	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.75e-05	0.00078	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.51e-05	0.000752	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	6.45e-05	0.000745	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—RAC1—dilated cardiomyopathy	6.41e-05	0.000741	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.39e-05	0.000737	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TMPO—dilated cardiomyopathy	6.31e-05	0.000729	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—LMNA—dilated cardiomyopathy	6.25e-05	0.000722	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.23e-05	0.00072	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	5.79e-05	0.000669	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TMPO—dilated cardiomyopathy	5.77e-05	0.000666	CbGpPWpGaD
Paclitaxel—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.67e-05	0.000654	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	5.5e-05	0.000635	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	5.5e-05	0.000635	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.41e-05	0.000625	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.35e-05	0.000617	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TNF—dilated cardiomyopathy	5.33e-05	0.000616	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TNF—dilated cardiomyopathy	5.31e-05	0.000614	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	5.3e-05	0.000612	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.26e-05	0.000608	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.26e-05	0.000608	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—LMNA—dilated cardiomyopathy	5.26e-05	0.000607	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—LMNA—dilated cardiomyopathy	5.26e-05	0.000607	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	5.24e-05	0.000605	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	5.24e-05	0.000605	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.24e-05	0.000605	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	5.23e-05	0.000604	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.2e-05	0.000601	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.2e-05	0.000601	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—LMNA—dilated cardiomyopathy	5.18e-05	0.000598	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—LMNA—dilated cardiomyopathy	5.08e-05	0.000587	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—NPPA—dilated cardiomyopathy	4.98e-05	0.000576	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	4.98e-05	0.000575	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ANKRD1—dilated cardiomyopathy	4.97e-05	0.000574	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—LMNA—dilated cardiomyopathy	4.92e-05	0.000568	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.89e-05	0.000565	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	4.85e-05	0.000561	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.83e-05	0.000558	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—LMNA—dilated cardiomyopathy	4.81e-05	0.000556	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—LMNA—dilated cardiomyopathy	4.74e-05	0.000547	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.72e-05	0.000545	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.7e-05	0.000543	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ANKRD1—dilated cardiomyopathy	4.68e-05	0.00054	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—TAZ—dilated cardiomyopathy	4.67e-05	0.00054	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.58e-05	0.000528	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.58e-05	0.000528	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—ACE—dilated cardiomyopathy	4.54e-05	0.000524	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—ACE—dilated cardiomyopathy	4.54e-05	0.000524	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.5e-05	0.000519	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—TAZ—dilated cardiomyopathy	4.4e-05	0.000508	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	4.39e-05	0.000507	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—ACE—dilated cardiomyopathy	4.38e-05	0.000506	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—LMNA—dilated cardiomyopathy	4.32e-05	0.000499	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.31e-05	0.000498	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.25e-05	0.000491	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—RAF1—dilated cardiomyopathy	4.25e-05	0.000491	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—ACE—dilated cardiomyopathy	4.25e-05	0.00049	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.23e-05	0.000489	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—SDHA—dilated cardiomyopathy	4.23e-05	0.000488	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—ACE—dilated cardiomyopathy	4.15e-05	0.00048	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.08e-05	0.000472	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.05e-05	0.000468	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—SDHA—dilated cardiomyopathy	3.98e-05	0.000459	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—LMNA—dilated cardiomyopathy	3.95e-05	0.000456	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.94e-05	0.000455	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—ACE—dilated cardiomyopathy	3.73e-05	0.000431	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—EGFR—dilated cardiomyopathy	3.72e-05	0.00043	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.53e-05	0.000408	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	3.51e-05	0.000406	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.51e-05	0.000405	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	3.5e-05	0.000405	CbGpPWpGaD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.47e-05	0.000401	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—ACE—dilated cardiomyopathy	3.41e-05	0.000394	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	3.4e-05	0.000392	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—TAZ—dilated cardiomyopathy	3.32e-05	0.000383	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	3.3e-05	0.000382	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.3e-05	0.000381	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TNF—dilated cardiomyopathy	3.27e-05	0.000377	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	3.2e-05	0.000369	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	3.09e-05	0.000357	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	3.06e-05	0.000354	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—SDHA—dilated cardiomyopathy	3e-05	0.000347	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	2.99e-05	0.000345	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—EGFR—dilated cardiomyopathy	2.92e-05	0.000337	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	2.91e-05	0.000336	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.9e-05	0.000335	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	2.89e-05	0.000334	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	2.88e-05	0.000333	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—AGT—dilated cardiomyopathy	2.88e-05	0.000332	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—AGT—dilated cardiomyopathy	2.88e-05	0.000332	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CD36—dilated cardiomyopathy	2.8e-05	0.000323	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—AGT—dilated cardiomyopathy	2.78e-05	0.000321	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.77e-05	0.000319	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—AGT—dilated cardiomyopathy	2.69e-05	0.000311	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—RAC1—dilated cardiomyopathy	2.64e-05	0.000305	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—AGT—dilated cardiomyopathy	2.63e-05	0.000304	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	2.63e-05	0.000304	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	2.61e-05	0.000301	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.58e-05	0.000298	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.54e-05	0.000294	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.51e-05	0.00029	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.47e-05	0.000286	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.47e-05	0.000286	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.43e-05	0.00028	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—AGT—dilated cardiomyopathy	2.36e-05	0.000273	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.36e-05	0.000273	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.3e-05	0.000266	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.26e-05	0.000261	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	2.22e-05	0.000256	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	2.21e-05	0.000255	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.2e-05	0.000254	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.2e-05	0.000254	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—AGT—dilated cardiomyopathy	2.16e-05	0.00025	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.13e-05	0.000246	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.12e-05	0.000245	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	2.08e-05	0.000241	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.06e-05	0.000237	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.02e-05	0.000233	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.01e-05	0.000232	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.94e-05	0.000224	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	1.92e-05	0.000222	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ITGB1—dilated cardiomyopathy	1.91e-05	0.000221	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.91e-05	0.00022	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	1.88e-05	0.000218	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.83e-05	0.000211	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NPPA—dilated cardiomyopathy	1.83e-05	0.000211	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.82e-05	0.00021	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.8e-05	0.000208	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	1.8e-05	0.000208	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.78e-05	0.000206	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.77e-05	0.000205	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PSEN2—dilated cardiomyopathy	1.77e-05	0.000204	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.76e-05	0.000204	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—RAF1—dilated cardiomyopathy	1.75e-05	0.000202	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.72e-05	0.000198	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.67e-05	0.000193	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.67e-05	0.000193	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.65e-05	0.000191	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	1.63e-05	0.000188	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD36—dilated cardiomyopathy	1.63e-05	0.000188	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.6e-05	0.000185	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.6e-05	0.000185	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.57e-05	0.000182	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.56e-05	0.00018	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.55e-05	0.000178	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—RAC1—dilated cardiomyopathy	1.54e-05	0.000177	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.49e-05	0.000172	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.47e-05	0.00017	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.42e-05	0.000164	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.33e-05	0.000153	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.26e-05	0.000146	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EGFR—dilated cardiomyopathy	1.2e-05	0.000138	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GPX1—dilated cardiomyopathy	1.15e-05	0.000133	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CD36—dilated cardiomyopathy	1.12e-05	0.000129	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GPX1—dilated cardiomyopathy	1.08e-05	0.000125	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.07e-05	0.000123	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.05e-05	0.000122	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CD36—dilated cardiomyopathy	1.05e-05	0.000122	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.03e-05	0.000119	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—RAF1—dilated cardiomyopathy	1.02e-05	0.000118	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AGT—dilated cardiomyopathy	1.01e-05	0.000116	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.95e-06	0.000115	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.69e-06	0.000112	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	9.68e-06	0.000112	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AGT—dilated cardiomyopathy	9.47e-06	0.000109	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.28e-06	0.000107	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—RAC1—dilated cardiomyopathy	8.89e-06	0.000103	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.76e-06	0.000101	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.73e-06	0.000101	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.66e-06	0.0001	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.25e-06	9.53e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GPX1—dilated cardiomyopathy	8.15e-06	9.41e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	8.12e-06	9.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.1e-06	9.35e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CD36—dilated cardiomyopathy	7.94e-06	9.17e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CD36—dilated cardiomyopathy	7.9e-06	9.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.89e-06	9.11e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	7.85e-06	9.07e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	7.64e-06	8.83e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AGT—dilated cardiomyopathy	7.15e-06	8.26e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	7.14e-06	8.25e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AGT—dilated cardiomyopathy	7.12e-06	8.22e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.1e-06	8.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	7.08e-06	8.18e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—dilated cardiomyopathy	6.98e-06	8.07e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CD36—dilated cardiomyopathy	6.95e-06	8.03e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	6.89e-06	7.96e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	6.88e-06	7.95e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AGT—dilated cardiomyopathy	6.26e-06	7.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	6.21e-06	7.17e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—RAF1—dilated cardiomyopathy	5.9e-06	6.81e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	5.12e-06	5.91e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.02e-06	5.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	4.98e-06	5.76e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	4.49e-06	5.18e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	4.43e-06	5.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	4.32e-06	4.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—dilated cardiomyopathy	4.04e-06	4.67e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.89e-06	4.49e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.86e-06	4.46e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.76e-06	4.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.61e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.51e-06	4.06e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.39e-06	3.91e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	3.16e-06	3.65e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.38e-06	2.75e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.32e-06	2.68e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.09e-06	2.41e-05	CbGpPWpGaD
